Targeted therapies in lung cancer

被引：35

作者：

Besse, B.

Ropert, S.

Soria, J. C.

机构：

[1] Inst Gustave Roussy, Dept Med, F-94800 Villejuif, France

[2] Hop Cochin, GHU Ouest, Dept Oncol, F-75674 Paris, France

来源：

ANNALS OF ONCOLOGY | 2007年 / 18卷

关键词：

GROWTH-FACTOR-RECEPTOR; PHASE-II TRIAL; PROTEIN-KINASE-C; TRANSFERASE INHIBITOR R115777; MATRIX-METALLOPROTEINASE; TYROSINE KINASE; ANTISENSE OLIGONUCLEOTIDE; ACTIVATING MUTATIONS; UNTREATED PATIENTS; IMPROVED SURVIVAL;

D O I：

10.1093/annonc/mdm308

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：135 / 142

页数：8

共 91 条

[1] Phase II study of the farnesyl transferase inhibitor r115777 in patients with advanced non-small-cell lung cancer [J].

Adjei, AA ;

Mauer, A ;

Bruzek, L ;

Marks, RS ;

Hillman, S ;

Geyer, S ;

Hanson, LJ ;

Wright, JJ ;

Erlichman, C ;

Kaufmann, SH ;

Vokes, EE .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (09) :1760-1766

[2]

Aghajanian C, 2002, CLIN CANCER RES, V8, P2505

[3]

Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994, N Engl J Med, V330, P1029, DOI 10.1056/NEJM199404143301501

[4]

[Anonymous], J CLIN ONCOL

[5] INITIAL CHEMOTHERAPEUTIC DOSES AND SURVIVAL IN PATIENTS WITH LIMITED SMALL-CELL LUNG-CANCER [J].

ARRIAGADA, R ;

LECHEVALIER, T ;

PIGNON, JP ;

RIVIERE, A ;

MONNET, I ;

CHOMY, P ;

TUCHAIS, C ;

TARAYRE, M ;

RUFFIE, P .

NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (25) :1848-1852

[6] Frequent activation of AKT in non-small cell lung carcinomas and preneoplastic bronchial lesions [J].

Balsara, BR ;

Pei, JM ;

Mitsuuchi, Y ;

Page, R ;

Klein-Szanto, A ;

Wang, H ;

Unger, M ;

Testa, JR .

CARCINOGENESIS, 2004, 25 (11) :2053-2059

[7]

Besse B, 2006, ANN ONCOL, V17, P218

[8] Phase 1 trial of flavopiridol combined with cisplatin or carboplatin in patients with advanced malignancies with the assessment of pharmacokinetic and pharmacodynamic end points [J].

Bible, KC ;

Lensing, JL ;

Nelson, SA ;

Lee, YK ;

Reid, JM ;

Ames, MM ;

Isham, CR ;

Piens, J ;

Rubin, SL ;

Rubin, J ;

Kaufmann, SH ;

Atherton, PJ ;

Sloan, JA ;

Daiss, MK ;

Adjei, AA ;

Erlichman, C .

CLINICAL CANCER RESEARCH, 2005, 11 (16) :5935-5941

[9]

Bible KC, 1997, CANCER RES, V57, P3375

[10] Phase III study of matrix metalloproteinase inhibitor prinomastat in non-small-cell lung cancer [J].

Bissett, D ;

O'Byrne, KJ ;

von Pawel, J ;

Gatzemeier, U ;

Price, A ;

Nicolson, M ;

Mercier, R ;

Mazabel, E ;

Penning, C ;

Zhang, MH ;

Collier, MA ;

Shepherd, FA .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (04) :842-849

← 1 2 3 4 5 6 7 8 9 10 →